Cyproheptadine inhibits in vitro and in vivo lung metastasis and drives metabolic rewiring.

MLA

Shannar, Ahmad, et al. “Cyproheptadine Inhibits in Vitro and in Vivo Lung Metastasis and Drives Metabolic Rewiring.” Molecular Biology Reports, vol. 51, no. 1, Nov. 2024, p. 1139. EBSCOhost, https://doi.org/10.1007/s11033-024-10033-6.

APA

Shannar, A., Sarwar, M. S., Dave, P. D., Chou, P. J., Peter, R. M., Xu, J., Pan, Y., Rossi, F., & Kong, A.-N. (2024). Cyproheptadine inhibits in vitro and in vivo lung metastasis and drives metabolic rewiring. Molecular Biology Reports, 51(1), 1139. https://doi.org/10.1007/s11033-024-10033-6

Chicago

Shannar, Ahmad, Md Shahid Sarwar, Parv Dushyant Dave, PoChung Jordan Chou, Rebecca Mary Peter, Jiawei Xu, Yuxin Pan, Fabio Rossi, and Ah-Ng Kong. 2024. “Cyproheptadine Inhibits in Vitro and in Vivo Lung Metastasis and Drives Metabolic Rewiring.” Molecular Biology Reports 51 (1): 1139. doi:10.1007/s11033-024-10033-6.